Retraction: Embelin Suppresses Osteoclastogenesis Induced by Receptor Activator of NF-κB Ligand and Tumor Cells In vitro through Inhibition of the NF-κB Cell Signaling Pathway

Ítems similars

• Embelin Suppresses Osteoclastogenesis Induced by RANKL and Tumor cells In Vitro Through Inhibition of the NF-κB Cell Signaling Pathway
  per: Reuter, Simone, et al.
  Publicat: (2010)
• Juglanin Inhibits Osteoclastogenesis in Ovariectomized Mice via the Suppression of NF-κB Signaling Pathways
  per: Zhang, Fangxue, et al.
  Publicat: (2021)
• Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
  per: Quan, Gui-Hua, et al.
  Publicat: (2015)
• Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand
  per: Yadav, Vivek R., et al.
  Publicat: (2011)
• Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
  per: Li, Xiucheng, et al.
  Publicat: (2021)